Published in Br J Haematol on December 01, 1979
Comparison of haematological indices between women of four ethnic groups and the effect of oral contraceptives. J Clin Pathol (1983) 1.09
Alpha thalassaemia in British people. Br Med J (Clin Res Ed) (1985) 1.08
Red blood cell size is inversely associated with leukocyte telomere length in a large multi-ethnic population. PLoS One (2012) 0.97
Oral contraceptives: effect of folate and vitamin B12 metabolism. Can Med Assoc J (1982) 0.95
Raised Coulter mean corpuscular volume in diabetic ketoacidosis, and its underlying association with marked plasma hyperosmolarity. J Clin Pathol (1983) 0.84
Haematinic deficiency and macrocytosis in middle-aged and older adults. PLoS One (2013) 0.81
Quantitative trait locus linkage analysis in a large Amish pedigree identifies novel candidate loci for erythrocyte traits. Mol Genet Genomic Med (2013) 0.81
Erythrocyte deformability in peripheral occlusive arterial disease. J Clin Pathol (1985) 0.80
Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma. World J Gastroenterol (2013) 0.77
Prevalence of urinary incontinence. Br Med J (1980) 7.11
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet (1986) 6.51
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet (1999) 5.36
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 5.17
The trouble with ethics committees. J R Coll Physicians Lond (1994) 5.07
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet (1994) 4.85
Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life. BMJ (1992) 4.53
Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions. J Clin Invest (1969) 4.45
Accuracy of diagnosis on death certificates compared with that in hospital records. Br J Prev Soc Med (1967) 4.17
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Strategies for prevention of osteoporosis and hip fracture. BMJ (1991) 3.78
Intrinsic-factor antibodies in absence of pernicious anaemia. 3-7 year follow-up. Lancet (1970) 3.36
Is coeliac disease underdiagnosed? Br Med J (1980) 3.26
Haemostatic function and cardiovascular death: early results of a prospective study. Lancet (1980) 3.25
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology (1987) 3.24
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol (1988) 3.21
Long term acid suppressing treatment in general practice. BMJ (1994) 3.11
Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet (1968) 3.10
Stress and relapse of breast cancer. BMJ (1989) 3.07
Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) (1984) 3.05
Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J (1979) 2.98
Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet (1984) 2.83
Population-based distributions of haemostatic variables. Br Med Bull (1977) 2.83
Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost (2000) 2.74
Enhancement of recovery from psychiatric illness by methylfolate. Lancet (1990) 2.73
Multicentre trial of physiotherapy in the management of sciatic symptoms. Lancet (1981) 2.59
Fetal and infant growth and cardiovascular risk factors in women. BMJ (1995) 2.52
Male infertility due to sulphasalazine. Lancet (1979) 2.51
How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) (1992) 2.49
Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet (1975) 2.40
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials. Br J Clin Pharmacol (1993) 2.39
Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology (1983) 2.23
Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology (1988) 2.20
Repeatability and validity of a modified activities of daily living (ADL) index in studies of chronic disability. Int Rehabil Med (1979) 2.14
Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). J Thromb Haemost (2006) 2.11
Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut (1986) 2.10
Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity. Am J Med (1969) 2.09
Macrocytosis of chronic alcoholism. Lancet (1974) 2.05
Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework. BMJ (1991) 2.02
Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet (1987) 1.99
Neutral-lipid storage disease: a new disorder of lipid metabolism. Br Med J (1975) 1.97
Studies of Y and Z, two hepatic cytoplasmic organic anion-binding proteins: effect of drugs, chemicals, hormones, and cholestasis. J Clin Invest (1971) 1.97
Elemental diets in treatment of acute Crohn's disease. Br Med J (1980) 1.92
Plasma concentrations of fibrinogen and factor VII in adult life and their relation to intra-uterine growth. Br J Haematol (1995) 1.91
Haemostatic variables associated with diabetes and its complications. Br Med J (1979) 1.90
Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc Res (1998) 1.90
Randomised controlled trial of yoga and bio-feedback in management of hypertension. Lancet (1975) 1.89
Ischaemic heart disease mortality risks for smokers and non-smokers. J Epidemiol Community Health (1979) 1.85
Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet (1987) 1.85
Remedial therapy after stroke: a randomised controlled trial. Br Med J (Clin Res Ed) (1981) 1.84
Food intolerance and Crohn's disease. Gut (1993) 1.84
Sulphasalazine and male infertility: reversibility and possible mechanism. Gut (1981) 1.80
Hemolytic anemia in Wilson's disease. N Engl J Med (1967) 1.78
Factors affecting birthweights in Hindus, Moslems and Europeans. Br J Obstet Gynaecol (1984) 1.77
Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ (1999) 1.76
Metabolic effects of oral neomycin. Clin Sci (1967) 1.73
Fibrinogen: a possible link between social class and coronary heart disease. Br Med J (Clin Res Ed) (1985) 1.67
Relationship of air temperature to various chemical, haematological, and haemostatic variables. J Clin Pathol (1979) 1.65
Reduction in hospital readmission stay of elderly patients by a community based hospital discharge scheme: a randomised controlled trial. BMJ (1988) 1.65
Ethnic group comparisons of variables associated with ischaemic heart disease. Br Heart J (1978) 1.63
Epidemiological and clinical picture of Addison's disease. Lancet (1968) 1.63
Anticonvulsant therapy, folic acid and vitamin B12 metabolism and mental symptoms. Epilepsia (1966) 1.62
The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology (1991) 1.61
Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. Br Med J (1980) 1.61
Phylogenetic study of organic anion transfer from plasma into the liver. Nat New Biol (1971) 1.60
The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease--a community-based study. Postgrad Med J (1995) 1.59
Dietary and other characteristics relevant for coronary heart disease in men of Indian, West Indian and European descent in London. Atherosclerosis (1988) 1.58
Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen. Lancet (1977) 1.58
The neuropsychiatry of megaloblastic anaemia. Br Med J (1980) 1.56
Factor VII in an industrial population. Br J Haematol (1974) 1.55
Reversible male infertility due to sulphasalazine: studies in man and rat. Gut (1984) 1.54
The physiological macrocytosis of pregnancy. Br J Obstet Gynaecol (1977) 1.53
Antithrombotic agents in coronary artery disease. Chest (2001) 1.53
Folate deficiency in the alcoholic--its relationship to clinical and haematological abnormalities, liver disease and folate stores. Br J Haematol (1975) 1.52
Observer variability in recording the peripheral pulses. Br Heart J (1968) 1.51
Haemostatic changes that constitute the hypercoagulable state. Lancet (1991) 1.47
Our lives and hard times. Lancet (1975) 1.47
Toxicity of trimethoprim-sulphamethoxazole in patients with megaloblastic haemopoiesis. Br Med J (1972) 1.46
Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci (1989) 1.46
Management of urinary incontinence in patients with multiple sclerosis. J R Coll Gen Pract (1981) 1.45
Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease. Arch Intern Med (2000) 1.44
Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial. Br Med J (Clin Res Ed) (1981) 1.44
Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut (1992) 1.42
Epidemiological characteristics of platelet aggregability. Br Med J (Clin Res Ed) (1985) 1.42
The prevalence of faecal and double incontinence. Community Med (1984) 1.42